Content about Company Location

LAS VEGAS — In many ways, the future of community pharmacy relies on evolving the role of the pharmacist to drive better patient adherence, improve health outcomes and perhaps most importantly, from a business perspective, to get paid for it. To help independent pharmacy owners and community pharmacists step closer to that future today, McKesson, the largest healthcare services company in the country, showcased Tuesday its Sponsored Clinical Services Network to hundreds of attendees here at McKesson ideaShare 2012.

LAS VEGAS — Three successful pharmacy innovators helped set a buoyant tone for the official kickoff of McKesson’s ideaShare 2012 conference here, as they shared success stories from their own community practice settings at a panel discussion hosted by Brian Tyler, president of McKesson U.S. Pharmaceutical.

CARSON, Calif. — The energy shot business in the mass market still is dominated by one player — Living Essentials’ 5-Hour Energy has almost 90% dollar share — but Sato Pharmaceutical, which boasts its Yunker Energy as the No. 1 energy shot in Japan, is looking to challenge that domination with the launch and support behind its Yunker Energy product across the United States. The overall category was up 9.3% to $194.5 million across food, drug and mass (excluding Walmart), according to SymphonyIRI Group data.


CARLISLE, Pa. — The Federal Trade Commission has approved Giant Food Stores' proposal to acquire 15 Genuardi's stores from Safeway.

The announcement follows Giant's Jan. 5 announcement that it would acquire the Genuardi's stores, all of which are located in the greater Philadelphia market. Giant also noted that under the terms of a consent order approved by the FTC, the Genuardi's located in Newtown, Pa., will be purchased by Newtown Market and will be operated as a McCaffrey's supermarket.

ABBOTT PARK, Ill. — Abbott on Tuesday announced the launch of Ensure Clear, a nutrition beverage available in peach and blueberry pomegranate flavors that offers three times more protein than juice, according to the company, and 21 vitamins and minerals to help adults looking to fill dietary gaps.

AMSTERDAM — Royal Ahold's U.S. subsidiary saw net sales jump 2.8% to $7.8 billion during first quarter 2012, the company said Wednesday.

WOONSOCKET, R.I., and HACKENSACK, N.J. — Retail-based clinic operator MinuteClinic, which is owned by CVS Caremark, is partnering with Hackensack University Health Network, the largest provider of inpatient and outpatient health services in New Jersey, in a clinical affiliation that expands access to healthcare services in northeast New Jersey.

NEW YORK — An article recently published in the Journal of the American Medical Association shed a highly positive light on the convenient care industry, and outlined significant ways in which retail-based clinics are playing an important role in today’s U.S. healthcare system by improving access, cost and coordination of care for patients.

At first blush, there appears to be nothing special about Dollar General’s first Southern California store in the suburb of Montclair. It occupies about 7,500 sq. ft. of space in an aging strip center, and a small banner hung on the exterior beckons to passing motorists and pedestrians, “Now Open.” Inside, more signs explain the bare-bones merchandising of familiar brands to shoppers unfamiliar with the Dollar General value proposition.

BRIDGEWATER, N.J. — Amneal Pharmaceuticals is adding blackberry flavoring to a generic diabetes drug following feedback from customers, the company said Wednesday.

Amneal announced the changes to its metformin hydrochloride immediate-release tablets in the 500-mg, 850-mg and 1,000-mg strengths, designed to cover up the smell of metformin.

ALBANY, N.Y. — With state-led Medicaid redesign and federal healthcare delivery reform under way in New York state, the demand for nurse practitioners, physicians assistants and other healthcare professionals is anticipated to continue to increase, according to a recent report by the Healthcare Association of New York State, which is a statewide hospital and continuing care association.

NEW YORK — The Food and Drug Administration has approved a new treatment for a rare genetic disorder that affects 10,000 people worldwide.

Pfizer and Protalix BioTherapeutics announced Wednesday the approval of Elelyso (taliglucerase alfa), an enzyme-replacement therapy for the long-term treatment of Type 1 Gaucher disease.